Categories AllCompany newsData & digitalESGIndustry recognitionsIndustry trendsLeadership appointmentsPartnerships & collaborationsPatient-focusRegionalTherapeutic areas Year All202420232022 September 5, 2024 Quotable: Words Of Wisdom From Our Recent APAC Coverage Read more September 4, 2024 Parexel Appoints SVP of RWE Operation Read more September 4, 2024 Parexel powers up real-world research capabilities with new senior vice president Read more September 3, 2024 Billion-dollar Raleigh development scores big lease for global HQ Read more September 3, 2024 Parexel to relocate global headquarters to North Hills in Raleigh Read more August 30, 2024 Embracing FSPs: Q&A with Jenny Denney Read more August 14, 2024 Parexel’s greenhouse gas reduction targets achieve SBTi validation Read more August 5, 2024 Parexel's 2023 ESG Report Highlights Significant Women Representation in Workforce Read more July 31, 2024 First Class Rail Incentive Accelerates Modal Shift for Parexel Read more July 30, 2024 RBQM: Moving Beyond a Belt and Suspenders Approach to Data Quality Read more July 24, 2024 Quality Considerations for Using AI in Bio/Pharma Read more July 23, 2024 The Clinical Research Data Sharing Alliance Announces Two New Board Members Read more July 22, 2024 Will anti-homosexuality bills in sub-Saharan Africa impede HIV research? Read more July 9, 2024 AI in Clinical Research: Decoding Regulatory Expectations Read more July 2, 2024 "All Hands on Deck" for Empathetic Patient Centricity Read more June 26, 2024 Quality Considerations in Changing Excipient Providers Read more June 18, 2024 CRO Industry Report: R&D trends, challenges in today's market, and growth drivers and opportunities Read more June 14, 2024 A floor at Harbor Hospital where patients participate in early clinical trials just got a $10 million facelift Read more June 14, 2024 How federated data networks can empower clinical research Read more June 13, 2024 Firm grows local presence with $10M upgrade to drug testing facility Read more June 11, 2024 DCTs no longer? Decentralised solutions in post-pandemic clinical trials Read more June 7, 2024 “Real” Evidence Generating Real Pre- and Post-Market Benefits Read more June 7, 2024 Back to (Communication) Basics: Reducing Site Burden and Establishing a Sponsor/CRO-of-Choice Relationship with Investigative Sites Read more May 24, 2024 Parexel releases report on advancing precision oncology Read more May 23, 2024 Making the case for fair compensation in clinical trials Read more May 1, 2024 As AI proliferates in pharma, regulators look to catch up in clinical trials Read more April 29, 2024 Parexel and Palantir Expand Collaboration to Leverage AI Capabilities in Clinical Trials Read more April 25, 2024 Parexel, Palantir Expand AI Alliance Read more April 25, 2024 Parexel strikes multi-year deal with Palantir for clinical trial AI Read more April 17, 2024 Achieving patient-guided drug development: putting the patient experience first Read more April 16, 2024 Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back? Read more April 12, 2024 The Role of Human Oversight With Artificial Intelligence in Clinical Research Read more April 11, 2024 Benefits Patients Will See With the Integration of AI Into Clinical Research Read more April 10, 2024 Industry Collaboration in Advancing Clinical Technology Read more April 9, 2024 Integrating AI Into Clinical Trials Read more April 8, 2024 The State of AI in Clinical Development Read more April 5, 2024 The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes Read more March 20, 2024 Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA's MASC Read more March 1, 2024 CAR-T boxed warnings: What comes next? Read more February 15, 2024 US Drug Pricing Reimbursement: Players, Payers, PBMs, and Prospects – A Conversation with Two Experts Read more February 7, 2024 Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends Read more February 1, 2024 The Healthcare Sector’s Increased Demand for Clinical Innovation: Q&A With Peyton Howell, Chief Operating and Growth Officer, Parexel Read more January 3, 2024 Trendspotting: What’s Coming for Clinical Trials and Research in 2024 Read more
September 4, 2024 Parexel powers up real-world research capabilities with new senior vice president Read more
August 5, 2024 Parexel's 2023 ESG Report Highlights Significant Women Representation in Workforce Read more
June 18, 2024 CRO Industry Report: R&D trends, challenges in today's market, and growth drivers and opportunities Read more
June 14, 2024 A floor at Harbor Hospital where patients participate in early clinical trials just got a $10 million facelift Read more
June 7, 2024 Back to (Communication) Basics: Reducing Site Burden and Establishing a Sponsor/CRO-of-Choice Relationship with Investigative Sites Read more
April 29, 2024 Parexel and Palantir Expand Collaboration to Leverage AI Capabilities in Clinical Trials Read more
April 17, 2024 Achieving patient-guided drug development: putting the patient experience first Read more
April 16, 2024 Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back? Read more
April 12, 2024 The Role of Human Oversight With Artificial Intelligence in Clinical Research Read more
April 11, 2024 Benefits Patients Will See With the Integration of AI Into Clinical Research Read more
April 5, 2024 The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes Read more
March 20, 2024 Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA's MASC Read more
February 15, 2024 US Drug Pricing Reimbursement: Players, Payers, PBMs, and Prospects – A Conversation with Two Experts Read more
February 7, 2024 Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends Read more
February 1, 2024 The Healthcare Sector’s Increased Demand for Clinical Innovation: Q&A With Peyton Howell, Chief Operating and Growth Officer, Parexel Read more
